Chapman University

Chapman University Digital Commons
Pharmaceutical Sciences (MS) Theses

Dissertations and Theses

Spring 5-2020

Effect of Diabetes Mellitus on Ocular Surface Tight Junctions and
Glycocalyx
Saleh M. Alfuraih
Chapman University, alfuraih@chapman.edu

Follow this and additional works at: https://digitalcommons.chapman.edu/
pharmaceutical_sciences_theses
Part of the Other Pharmacy and Pharmaceutical Sciences Commons

Recommended Citation
Alfuraih, SM. Effect of Diabetes Mellitus on Ocular Surface Tight Junctions and Glycocalyx. [master’s
thesis]. Irvine, CA: Chapman University; https://doi.org/10.36837/chapman.000128

This Thesis is brought to you for free and open access by the Dissertations and Theses at Chapman University
Digital Commons. It has been accepted for inclusion in Pharmaceutical Sciences (MS) Theses by an authorized
administrator of Chapman University Digital Commons. For more information, please contact
laughtin@chapman.edu.

Effect of Diabetes Mellitus on Ocular Surface Tight Junctions and Glycocalyx
A Thesis by
Saleh Mohammed G Alfuraih

Chapman University
Irvine, CA
School of Pharmacy
Submitted in partial fulfillment of the requirements for the degree of
Master of Science in Pharmaceutical Sciences
May 2020

Committee In charge:
Dr. Ajay Sharma., Chair
Dr. Surya Nauli
Dr. Khaled Elsaid

The thesis of Saleh Mohammed G Alfuraih is approved

_________________________
Ajay Sharma, Ph.D., Chair

_________________________
Surya Nauli, Ph.D

_________________________
Khaled Elsaid, Ph.D

April 2020

Effect of Diabetes Mellitus on Ocular Surface Tight Junctions and Glycocalyx
Copyright © 2020
by Saleh Mohammed G Alfuraih

III

ACKNOWLEDGEMENTS
In the beginning, I would like to express my honest gratitude to my mentor and
advisor, Dr. Ajay Sharma, Assistant Professor of Pharmacology, Chapman University
School of Pharmacy, for his continued support, and his vast knowledge, guidance,
motivation during my master's program and my thesis research.
I would also like to thank my committee members: Dr. Surya Nauli, Professor, and
Dr. Khaled Elsaid, Associate Professor of Pharmacology, Chapman University School of
Pharmacy, for their insightful comments, constructive feedback, and suggestion.
My thanks also go to our lab technicians Mr. Cristopher Ross and Mrs. Ashley Barbarino
for their technical support. Many thanks also to my lab mates Mr. Kiumars Shamloo, Mr.
Jacob Baker, and Ms. Priya Mistry for their kind assistance.
Further, I am grateful to all the professors and lecturers who have taught me and
provided me valuable advice during the master's program. especially Dr. Keykavous
Parang and Dr. Innokentiy Maslennikov. My thanks are also due to Mrs. Sandra Robbie
who always has her office doors open to serve the students. Also, I would like to thank
staff of the core lab for their help and support.
Furthermore, the words cannot express how grateful I am to my father
(Mohammed) and mother (Hessah), who are always caring, supporting, inspiring, and
praying for me since I was a child and until now. I am also very grateful to all my family
members especially my brothers, Ibrahim, Ghazi, Khalid, Abdullah, Faisal, Abdulrahman,
Abdulaziz, Ali, Hamed, and to my sisters, Munirah, Rogyah, Norah, Maha, and Rouff, for
their prayers, encouragements, emotional and moral supports. The journey of life cannot
be complete without my better half, and from the bottom of my heart, I would like to thank

IV

my wife, Munirah, and also my lovely daughter, Hessah, who deprived themselves from
many things and facilitated all comfort for helping me to study hard during the program.
Many thanks also to my nephews, nieces and friends for their prayers and supports.
Ultimately, I am grateful to the best country around the world, the Kingdom of Saudi
Arabia, for the scholarship and financial support to study in the United States of America.
Also, special thanks to my sponsor Northern Border University, Ministry of Higher
Education, Saudi Culture Mission in the United States of America, for their support,
guidance, and advice.

V

ABSTRACT
Effect of Diabetes Mellitus on Ocular Surface Tight Junctions and Glycocalyx
by Saleh Mohammed G Alfuraih
Diabetes mellitus is the disease of the century that affects many body organs. In
the eye, diabetes mellitus causes retinopathy, cataract, glaucoma, papillopathy, and
ocular surface disease. Ocular surface abnormalities in patients of diabetes mullites
include impairment of corneal epithelial barrier function, conjunctival defects, increased
incidence of corneal and conjunctival infections and higher prevalence of dry eye disease.
Impairment of tight junctions and glycocalyx, which are critical for ocular surface barrier
function, may underlie these diabetes-associated ocular surface defects. Therefore, the
present study was designed to investigate the effect of high glucose exposure and type I
diabetes mellitus on the conjunctival tight junction proteins, tear secretion and corneal
glycocalyx.
Cultured human conjunctival epithelial cells were exposed to high glucose (15 mM
and 30mM) concentrations for 24 and 72 hours. Trans-epithelial electrical resistance and
scratch assay were performed to quantify barrier functions and cell migration. Gene and
protein expression of tight junction proteins: claudin-1, claudin-2, claudin-3, ZO-1, ZO-2,
ZO-3, and occludin was quantified using real time PCR and western blotting. Type I
diabetes was induced in mice by streptozotocin injection. Phenol red thread test,
fluorescein staining and wheat-germ agglutinin corneal staining and confocal microscopy
of whole mount corneas were performed to quantify tears, keratopathy and corneal
glycocalyx area.
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Our data demonstrates that high glucose causes a significant decrease in transepithelial electrical resistance of cultured human conjunctival epithelial cells. However,
high glucose did not modulate the cellular migration or protein expression of claudin-1,
ZO-1,-2,-3 or occludin. Interestingly, an increase in gene expression of all the tight
junction proteins was observed at 72-hour exposure with 15 mM glucose. This effect on
gene expression is likely due to the cellular osmotic stress caused by glucose since
mannitol also caused the similar increase after 72 hours exposure. Type I diabetes
caused a significant decreased in the tear film volume which was accompanied by corneal
keratopathy and a decrease in the area of corneal glycocalyx. In summary, our data
demonstrates that high glucose impairs the conjunctival epithelial cell barrier functions,
but the alterations in cellular migration and tight junction proteins are not the likely cause
of conjunctival epithelial barrier dysfunction. Type I diabetes mellitus causes tear film
abnormalities and corneal keratopathy which is accompanied by a concurrent decrease
in corneal glycocalyx.
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CHAPTER I
INTRODUCTION
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Diabetes mellitus is an endocrine disease characterized by persistently high levels
of blood glucose that can cause many serious health issues [Brownlee, 2001; Forbes and
Cooper, 2013; Sayin et al., 2015]. The incidence of diabetes mellitus is alarmingly rising
all over the world and it will be of epidemic proportions in the near future [Whiting et al.,
2011]. Approximately 240 million people worldwide are affected by diabetic mellitus, and
this number is going to increase nearly to 370 million by 2030 [IDF Diabetes Atlas, 2019].
The countries experiencing the highest incidence of diabetes are China, India and United
States. In the United States, more than 30 million people are suffering from diabetes
mellitus and surprisingly a large percentage of population is prediabetic [American
Diabetes Association statistics, 2019].
Diabetes mellitus causes significant morbidity especially due to microvascular
complications resulting in neuropathy, nephropathy and retinopathy [Brownlee, 2001;
Forbes and Cooper, 2013]. Besides retinopathy, diabetes mellitus also can cause many
other ocular complications such as ocular surface diseases [Yoon et al., 2004], glaucoma
[Zhao and Chen., 2017], cataract [Pollreisz and Schmidt-Erfurth, 2010] and diabetic
papillopathy [Regillo et al., 1995; Bayraktar et al., 2002]. Incidence of corneal keratopathy
and persistent corneal epithelial defects is disproportionally high in patients of diabetes
mellitus [Ljubimov, 2017]. Abnormalities in epithelial cell density or alterations in the
corneal epithelial maturation have also been detected in the cornea of diabetes mellitus
patients [Ljubimov, 2017; Barsegian et al., 2018]. Clinical studies using anterior
fluorometry-assisted tracking of corneal fluorescein penetration have consistently
demonstrated an impairment of corneal epithelial barrier function in diabetic patients
[Gekka et al., 2004]. These studies have also shown that the frequency and severity of
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corneal epithelium barrier impairment correlated with the serum levels of HbA1c [Gekka
et al., 2004]. In addition to these corneal barrier function abnormalities, patients of
diabetes mellitus have been reported to suffer from conjunctival defects as well.
Abnormalities in conjunctival capillaries, including dilatation, increased tortuosity and
leakage, have been reported in patients suffering from diabetes mellitus [Cheung et al.,
2001; Owen et al., 2008]. Patients with diabetes mellitus suffer from significantly higher
incidence of corneal and conjunctival infections [Ljubimov, 2017]. The corneal and the
conjunctival epithelial cells express high level of tight junction proteins that serve as a
strong barrier against any microbial invasion [Ban et al., 2003; Yoshida et al., 2009]. There
are more than 40 protein in tight junctions which help to regulates the movement of
macromolecules, ions, and water [Yoshida et al., 2009]. These proteins also play an
important role in maintaining the cell polarity by regulating the lipids distributions within
the membrane [Campbell et al., 2017]. Diabetes mellitus has been shown to alter the
expression of tight junctions in many tissues include retina, cardiac, neuronal, renal cells
[Barber et al., 2000; Dias and Griffiths, 2014; Mongelli-Sabino et al., 2017].
Glycocalyx is a layer that covers the plasma membrane of many cells. It is made
up of glycoproteins, proteoglycans and glycosaminoglycans. It functions as a barrier
between the cells and their surroundings [Egberts et al., 1984; Devuyst et al., 2014;
Alphonsus and Rodseth, 2014].The ocular surface glycocalyx is made up of a network of
corneal epithelial membrane bound glycosylated mucins MUC1, MUC4, MUC16 and
galactin-3 [Mantelli et al., 2013].This glycocalyx serves as a protective barrier in addition
to the tight junction proteins expressed by ocular surface epithelial cells [Mantelli et al.,
2013]. The glycocalyx also serves an important function of retaining water and keeping
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the ocular surface moist [Prydal et al., 1992; Davidson and Kuonen, 2004]. Our lab and
other research groups have demonstrated that systemic diseases can cause an alteration
in corneal glycocalyx [Uchino, 2018; Shamloo et al., 2019]. Our lab has also
demonstrated that exposure of cultured corneal and conjunctival epithelial cells to high
glucose causes alterations in the gene expression of MUC1, MUC 4 and MUC16
[Unpublished data].
Dry eye syndrome or keratoconjunctivitis sicca is an ocular surface disease that
can cause feeling of dryness, redness and foreign body sensation in the eye. If left
untreated it can cause damage to the cornea and conjunctiva resulting in significant visual
morbidity. The incidence of dry eye is significantly higher in diabetic patients [Yoon et al.,
2004; Sayin et al., 2015; Misra et al., 2016]. Tear film is made up of muco-aqueous layer
covered by a lipid layer. Tear film is an important part of the eye and plays a role to protect
the ocular surface from infections, mechanical damage and keeps it hydrated and
lubricated. Studies have shown that diabetic patients have decreased tear production, an
abnormal ocular surface sensitivity and higher incidence of dry eye [Rosenberg et al.,
2000; Yoon et al., 2004; Alves et al., 2008; Misra et al., 2016]. Moreover, increased
osmolarity of tears and inflammation of ocular surface has also been reported in patients
suffering from diabetes mellitus [Fuerst et al., 2014; Sağdık et al., 2013].
The impact of diabetes mellitus-associated hyperglycemia on tight junction
proteins and ocular surface glycocalyx has not been investigated. If diabetes mellitus
adversely affects the tight junction proteins and the integrity of ocular surface glycocalyx,
such damage may account for the loss of ocular surface barrier integrity and the higher
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incidence of corneal/conjunctival infections and dry eye observed in patients of diabetes
mellitus.
Our central hypothesis is that high glucose due to diabetes mellites causes
impairment of ocular surface barrier functions by decreasing the expression of tight
junction proteins and causing redaction in glycocalyx. Therefore, the present study is
designed to investigate:
Aim 1: the effect of acute (24 hours) and chronic (72 hours) high glucose exposure on
the tight junction proteins using cultured human conjunctival epithelial cells.
Aim 2: the effect of type I diabetes mellitus on tear secretion and ocular surface
glycocalyx using a mouse model of type I diabetes.
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CHAPTER II
LITERATURE REVIEW
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Ocular Surface, Glycocalyx, Lacrimal Functional Unit and Tear film
The ocular surface is made up of cornea and conjunctiva. It is covered by a thin layer of
fluid called tear film.
i.Conjunctiva
The term “conjunctiva” comes from the Latin word meaning "to bind together." The
conjunctiva is a semi-transparent thin membrane that covers the eyeball above the sclera
and the inner surface of the eyelids. The conjunctiva covering the sclera is referred to as
bulbar conjunctiva and the conjunctiva covering under the eyelids is termed as palpebral
conjunctiva (Figure 1A). The palpebral conjunctiva is further divided into marginal, tarsal
and orbital conjunctiva [Chigbu, 2013].

A
B
Figure 1: Anatomy (A) and histology (B) of conjunctiva.
(https://www.sciencephoto.com/media/703697/view/conjunctiva-illustration-illustration;A)
(https://www.slideshare.net/kmrhssl/anatomy-of-conjunctiva B)

Histologically, conjunctiva consist of two layers (Figure 1B): the epithelium and the
substania propria [Shields and Shields, 2019]. The conjunctival epithelium consists of two
to seven layers of nonkeratinized, stratified columnar epithelial cells joined by tight
junction and desmosomes to provide barrier against the environmental insults. The
conjunctival epithelium has also abundant goblet cells; which secrete mucins into the tear
film [Kim et al., 2011; Uchino et al., 2013].
7

ii.Limbus
Limbus is anatomically indistinguishable but histologically distinct circular area that
forms the junction between conjunctiva and cornea (Figure 2). In humans, it is about 1.5
mm wide. Limbus contains stem cells and its primary function is to continually regenerate
conjunctival and corneal epithelial cells [Van Buskirk, 1989; Chigbu, 2013; Sridhar, 2018].
The epithelial cells generated by limbus migrate to cover the ocular surface. The
conjunctival side of limbus has between eight to ten layers of epithelial cells. Limbal
conjunctival epithelium is continuous with the epithelium of the bulbar conjunctiva [Van
Buskirk, 1989; Sridhar, 2018].

Figure 2: Anatomical location of limbus. (Riordan-Eva et al., 2018)
iii.Cornea
The cornea is a thin transparent tissue with an average thickness of 550 μm and
an average diameter of about 11.7 mm horizontally and 10.6 mm vertically in adult
humans. Histologically, the cornea has five different layers, including epithelium,
bowman's layer, stroma, Descemet's membrane, and endothelium. The corneal
epithelium has approximately five or six layers of cells that are in continuation with the
epithelium of the limbus and bulbar conjunctiva. Cornea has three different types of
epithelial cells which include squamous, wing and basal cells. The corneal epithelium
8

provides a substantial barrier to protect the eye from any external materials such as dust,
microorganism, and allergens [Chigbu and Coyne, 2015; Sridhar, 2018].
iv.Glycocalyx
The glycocalyx is thin “fuzzy” layers made up of glycoproteins, proteoglycans and
glycosaminoglycans covering the external part of the plasma membrane of cells. In
humans, the thickness of glycocalyx varies from organ to organ approximately being 0.5
to 5.0 μm [Uchimido et al., 2019]. In ocular surface, glycocalyx is about 0.5 μm thick
[Uchino, 2018]. Glycocalyx serves as barrier between the cells and the surrounding
environment [Alphonsus and Rodseth, 2014; Devuyst et al., 2014]. It protects the cell
membrane from any stress or physical actions that affect its integrity [Monne et al., 2013].
Glycocalyx can be altered in many diseases and also influences the properties of cell
membranes [Uchino, 2018, Shamloo et al., 2019]. The ocular surface corneal and
conjunctival epithelial cells produce O-glycosylated transmembrane mucins including
MUC1, MUC4 and MUC16. These membrane-bound mucins and galactin-3 together form
the glycocalyx at the ocular surface epithelia (Figure 3) working to protect the cells from
any chemical or mechanical damages [Mantelli et al., 2013]. In addition, it plays an
important function of keeping the ocular surface lubricated and moist [Davidson and
Kuonen, 2004].
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Figure 3: Ocular Surface Barrier consisting of glycocalyx and intercellular
junctions. (Mantelli et al., 2013)
v.Lacrimal function unit
It consists of meibomian gland, lacrimal gland, lids, conjunctiva, and cornea and
the sensory nerves innervating these structures (Figure 4). Together, lacrimal functional
unit is responsible for secretion and maintenance of the tear film [Stern et al., 2004].

Figure 4: Parts of eye that contribute to tear film.
(http://retina-ded.org/diabetic-dry-eye-syndrome/dry-eye-syndrome-and-diabetes)

vi.Tear Film
The tear film in humans consists of two layers, the muco-aqueous layer primarily
secreted by conjunctiva, cornea and the lacrimal gland and the lipid layer secreted the
meibomian gland [Dartt and Willcox, 2013]. The tear film serves the important functions
of maintaining humid environment to avoid the ocular surface from becoming dry,
lubricating it for smooth eyelids movement, inhibiting the growth of microorganisms by
10

flushing, and providing the cornea with oxygen and nutrients. Normally the tear volume in
each eye varies roughly from 2 to 7 µl. The tear film contains albumin, immunoglobulins
IgA, IgG and IgE, lysozymes, potassium, sodium, chloride, glucose and urea [McDermott,
2013]. The deficiency of tear film can lead to dry eye disease and abnormalities in the
ocular surface epithelium. The patients who suffer from dry eyes have many symptoms
such scratchy sensation, itching, increase in mucus secretion, redness, burning, difficulty
of eyelids movement and pain [Ljubimov, 2017]. The dry eye syndrome can lead to
decreased vision, and if left untreated can cause corneal ulceration, corneal scarring,
corneal thinning and infections [Matossian et al., 2019].
Ocular Surface Barrier Function
The ocular surface is perpetually exposed to the external environment, which
makes it vulnerable to microbes, allergens, and chemicals. Corneal and conjunctival
epithelial cells form the outermost layer of the ocular surface and provide a substantial
barrier against these environmental insults. The tight junctions are highly expressed in
the ocular surface epithelial cells and serve to create a strong barrier to protects the eye
from outside environments [Ban et al., 2003; Yoshida et al., 2009; Mescher, 2018]. The
tightness of tight junction in corneal epithelium is greater as compared to conjunctival
epithelium [Yoshida et al., 2009].
Biology of Inter-cellular Junctions
The intercellular junctions are made up of i) tight junctions, ii) adherens junctions,
and iii) desmosomes (Figure 5). Both corneal and conjunctival epithelial cells express
these intercellular junctions [Yoshida et al., 2009].
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Figure 5: Various types of inter-cellular junctions. (Mescher, 2018)
i)Tight junctions
Tight junctions are localized on the apical surface of epithelial cells. One of the
significant functions attributed to the tight junctions is to restrict the paracellular movement
of large molecules, ions and pathogens, thus significantly contributing to the barrier
function of epithelial cells [Anderson and Van Itallie, 2009; Leong and Tong, 2015; Lee et
al., 2018]. These junctions contain an assembly of integral transmembrane proteins that
are further connected to the peripheral membrane proteins present in the cytosol (Figure
7). Four transmembrane proteins present in the tight junctions include claudins, occludin,
junctional adhesion molecules, and tricellulin [Itoh and Bissell, 2003; Anderson and Van
Itallie, 2009; Lee et al., 2018]. The peripheral proteins are zonula occludens such as ZO1, ZO-2, ZO-3 and serve to connect the transmembrane proteins to the cytoskeletal
proteins [Itoh and Bissell, 2003; Anderson and Van Itallie, 2009; Lee et al., 2018].
The claudins protein family consists of 27 members who share a common feature
of four transmembrane spanning region, forming two extracellular loops and cytosolic C
and N terminals [Krause et al., 2008; Tsukita et al., 2019]. Claudins demonstrate a tissuespecific distribution with various combinations of the 27 subtypes being expressed in the
12

epithelial cells of different organs [Krause et al., 2008; Tsukita et al., 2019]. Claudin-1,2,-4,-7,-9, and Claudin -14 expressions have been detected in both human corneal and
conjunctival epithelial cells. However, claudin- 3 was detected only in corneal epithelial
cells and claudin-10 being selectively expressed in the conjunctival epithelial cells
[Yoshida et al., 2009].
Expression of occludin has also been detected in the corneal and conjunctival
epithelial cells [Yoshida et al., 2009]. Like claudins, occludin also has four transmembrane
domains and two extracellular loops [Krause et al., 2008; Cummins, 2012]. However, the
function of occludin in tight junctions is less clear as compared to claudins. Occludin is
proposed to regulate the movement of large macromolecule across the tight junction
barrier. Occludin is phosphorylated at threonine and serine residues and upon
phosphorylation it is mainly localized in the plasma membrane. Dephosphorylation of
occludin leads to its migration to cytoplasm [Cummins, 2012]. The phosphorylation of
occludin seems to be essential in interacting with other tight junction proteins like ZO-1
[Cummins, 2012; Bhat et al., 2019] Consequently, the phosphorylation of occludin may
maintain the permeability and stability of tight junctions [Bhat et al., 2019] whereas its
dephosphorylation may promote leakiness [Bhat et al., 2019].
The junctional adhesion molecules are also the important component of tight
junctions [Itoh and Bissell, 2003; Anderson and Van Itallie, 2009; Lee et al., 2018]. These
molecules structurally belong to immunoglobulin like single span family of proteins and
have an extracellular domain, a single transmembrane domain and a cytoplasmic tail [Itoh
and Bissell, 2003; Anderson and Van Itallie, 2009; Lee et al., 2018]. Junctional adhesion
molecules interact with adjacent cell’s tight junction by the extracellular domain. The
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cytoplasmic tail is involved in cytosolic protein interactions. Besides, playing a role in tight
junction formation, junctional adhesion molecules also play a role in cell proliferation and
migration [Itoh and Bissell, 2003].

Figure 6: Various protein components of tight junctions and adherence
junctions. (Singh et al., 2010)
Zonula occludens, ZO-1, ZO-2, ZO-3, connect the junctional proteins claudin and
occludin to actin cytoskeleton. These proteins have also been shown to be present in the
tight junctions of corneal and conjunctival epithelial cells [Itoh and Bissell, 2003; Anderson
and Van Itallie, 2009; Lee et al., 2018; Bhat et al., 2019]. The roles of ZOs proteins in tight
junctions is still under investigation. Studies show that cells deficient in ZO-1 could still
preserve the tight junction structure and function and demonstrate the normal
permeability barrier but have a delay in the expression of occludin and claudins [Itoh and
Bissell, 2003; Anderson and Van Itallie, 2009; Lee et al., 2018; Bhat et al., 2019] On the
other hand, epithelial cells deficient in ZO-2 and ZO-3 did not have any notable effect on
their tight junctions. [Lee et al., 2018].
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ii)Adherens junctions
Adherens junctions or zonula adherens are localized below the tight junctions in
the polarized epithelial cells at the apical region of the intercellular cleft and act as a
zipper-like seal between adjacent cells [Niessen, 2007; Campbell et al., 2017; Shigetomi
et al., 2018] The adherens junctions maintain the cell-cell adhesion, regulate the
organization of the actin cytoskeleton and also play a role in the gene transcription
[Niessen, 2007; Campbell et al., 2017; Shigetomi et al., 2018]. Structurally, adherens
junctions contains E-cadherin, p120 catenin, beta-catenin, and alpha-catenin. Along with
cadherins, catenins are also essential for formation, function, and maintenance of
adherens junctions [Niessen, 2007; Campbell et al., 2017; Shigetomi et al., 2018].
iii)Desmosomes
Desmosomes, also known as macula adherens, are located at the basal side of
the epithelia. The desmosomes have unique structures like disc shapes with two identical
structures that match the adjacent cell surface. The desmosomes consist of proteins from
cadherins family, which include desmocollin and desmoglein [Garcia et al., 2018].
Desmosomes also contain Armadillo proteins family proteins, plakoglobin and plakophilin
[Garcia et al., 2018]. Desmosomes play an essential role in providing strength to the cell
conjunction and cytoskeleton. Desmosomes may also work as a strong barrier between
the cells.
Diabetes Mellitus: Etiology and Epidemiology
Diabetes mellites has the origin of its name in Greek word diabetes meaning "to
siphon" and the Latin word mellitus meaning "sweet" [Cowap and Parry, 2015]. denoting
the key disease symptom of excessive passing of sweet-tasting urine. Diabetes mellitus
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is a serious metabolic disorder that has the phenotype of hyperglycemia. Diabetes
mellitus has several subtypes that are caused by an interaction between environmental
factors and genetics. The etiology of diabetes mellitus is multi-factorial. The diabetes
mellitus is classified based on the pathogenic process leading to hyperglycemia. There
are two main categories of diabetes mellitus, Type 1 and Type 2. Type 1 diabetes mellitus
is caused by an autoimmune response resulting in destruction of beta cells of pancreas.
This ultimately leads to almost complete insulin deficiency [Powers et al., 2018]. The type
2 diabetes mellitus is a heterogeneous disorder characterized by a combination of insulin
resistance, decreased insulin secretion and increased hepatic glucose production. The
other types of diabetes mellitus include those caused by genetic defects in insulin
secretion, action, and metabolic abnormalities that decrease insulin secretion,
abnormality of mitochondria and decreased glucose tolerance [Powers et al., 2018]. Also,
the mutation in insulin can cause rare disorders characterized by severe insulin
resistance. In some cases, the diabetes mellitus may be developed due to chronic
pancreatitis or cystic fibrosis, when the islets become damaged. [Powers et al., 2018].
According to the International Diabetes Federation publication “The Diabetes
Atlas”, the prevalence of diabetes mellitus has risen dangerously over the past few
decades. In 1985, there were approximately 30 million cases rising to a whopping 415
million cases in 2017. This number is further projected to rise to 642 million by 2040. In
2015, the countries with largest number of individuals suffering from diabetes mellitus
include China (109 million) followed India (73 million), then United States (30 million),
Brazil (14 million), and the Russian Federation (9 Million). As reported by the Center for
Disease Control and Prevention, the united states have 9.4% of the population diagnosed
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with diabetes. Additionally, there are about 34% more people who have prediabetes [Xu
et al., 2013; Cho et al., 2018; Powers et al., 2018].
While the number of patients of both type 1 and type 2 diabetes mellitus is
increasing around the world, the prevalence of type 2 diabetes mellitus is more rapidly
increasing compared to type 1. Life-style changes such as reduced physical activity level,
increased obesity, and the aging population has been proposed to contribute to the
increased incidence of diabetes mellitus. The rate of type 1 diabetes is also increasing by
roughly 5% per year around the world and patients are being diagnosed at younger ages.
The high incidence of diabetes mellitus will lead to tremendous health burden worldwide
[Powers et al., 2018].
High glucose-mediated Cellular and Pathological Alterations
Diabetes mellitus causes damage to many organs in the human body. The
vascular damage is considered to be a major underlying cause of many diabetesassociated complications. The diabetic complications based on vascular damage are
divided into two major categories: microvascular and macrovascular. The microvascular
complications are specifically thought to be responsible for diabetes-associated
neuropathy, nephropathy and retinopathy while the macrovascular complications account
for diabetes-associated coronary and peripheral artery diseases [Funk, 2019].
Strict regulation of duration and degree of hyperglycemia has been shown to
decrease diabetes-associated microvascular complications suggesting that high glucose
plays a critical role in diabetes-associated complications. Hyperglycemia has been
proposed to cause damage by four pathways (Figure 7): activation of polyol pathway,
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increased formation of advanced glycation end product (AGE), increased hexosamine
formation, and activation of the protein kinase C (PKC) [Funk, 2019].

Figure 7: Hyperglycemia-mediated cellular changes that trigger diabetesassociated complications. (Hammer and McPhee, 2018)
The polyol pathway has been proposed to constitute one-third of intracellular
glucose flux. Most of the cells have aldose reductase which is an enzyme reducing toxic
aldehyde to alcohol. When the concentration of glucose becomes high in the cells, the
polyol pathway converts the glucose to sorbitol then to fructose by oxidation. The pathway
utilizes nicotinamide adenine dinucleotide phosphate (NADPH) which is mandatory to
regenerate the glutathione and thiol. The pathway causes both the osmotic and oxidative
stress on the cells. However, recent evidence suggests the greater damage is because
of oxidative stress due to NADPH depletion rather than osmotic stress [Lorenzi, 2007].
The advanced glycosylation end-product (AGE) are formed by an initial nonenzymatic Millard reaction between the free amino groups of the proteins and carbonyl
group of glucose (Figure 9). AGE formation is subdivided into three stages. In early stage,
glucose reacts with free amino group of proteins to form unstable Schiff base intermediate
that then undergoes the Amadori rearrangement to be form more stable intermediate. In
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second stage, Amadori products degrade to dicarbonyl compounds such as
deoxyglucosones and glyoxal by oxidation and dehydration (Figure 8). In the last stage,
advanced glycosylation end-products (AGE) are formed by cyclization, oxidation and
dehydration reactions. Further increase in glycation leads to the protein cross linking
causing structural changes and accumulation of AGEs and crosslinked proteins [Singh et
al., 2014; Funk, 2019].

Figure 8: Chemical reaction between glucose and proteins leading to advanced
glycosylation end-products (AGE) formation. (Hammer and McPhee, 2018)
Excessive intracellular glucose causes increased de novo synthesis of
diacylglycerol (DAG) which activates the protein kinase C (PKC). Activation of PKC can
cause changes in gene expression which can cause excessive synthesis of extracellular
matrix, altered the blood flow and impaired the endothelial permeability [Koya and King,
1998].
Lastly, the hexosamine pathway also play an important role in diabetes-associated
microvascular diseases. The amino sugars synthesized by hexosamine pathway are
converted to fructose-6-phosphate, then to glucosamine-6-phosphate. Fructose-6phosphate-amidotransferase, the enzyme that catalyzes this reaction, uses glutamine as
donor. The glucosamine-6-phosphate is then converted and activated to uridine-519

diphosphate-N-acetylglucosamine which is the major precursor necessary for the
biosynthesis of glycoproteins, glycosaminoglycans, proteoglycans and glycolipids
[Schleicher and Weigert, 2000]. The overactivation of hexosamine pathway contributes
to the insulin resistance, stimulates the protein expression of transforming growth factorβ, plasminogen activator inhibitor and excessive synthesis of extracellular matrix [Buse,
2006].
Impact of Diabetes Mellitus on Ocular Surface Barrier and Tear Film
In the eyes, diabetes can cause diabetic retinopathy, dry eye syndrome, glaucoma,
and cataract [Bayraktar et al., 2002; Yoon et al., 2004; Pollreisz and Schmidt-Erfurth,
2010; Zhao and Chen., 2017]. Recent evidence suggests that diabetes can also have
major detrimental effect on the ocular surface [Rosenberg et al., 2000; Yoon et al., 2004;
Alves et al., 2008; Misra et al., 2016]. Patients of diabetes mellitus suffer from corneal
keratopathy and persistent corneal epithelial defects [Ljubimov, 2017]. The density of
corneal epithelial cells has been shown to be decreased in patients of diabetes mellitus
and the corneal epithelial cell maturation is delayed [Barsegian et al., 2018]. Anterior
fluorometry-assisted tracking of corneal fluorescein penetration has shown that patients
of diabetes mellitus have an impairment of corneal epithelial barrier function in diabetic
patients [Gekka et al., 2004]. These studies have also shown that the frequency and
severity of corneal epithelium barrier impairment correlated with the serum levels of
HbA1c [Gekka et al., 2004; Misra et al., 2016]. Patients of diabetes mellitus also show
abnormalities in conjunctival capillaries, such as dilatation, increased tortuosity and
leakage [Cheung et al., 2001; Owen et al., 2008]. Patients with diabetes mellitus also
suffer from significantly higher incidence of corneal and conjunctival infections [Ljubimov,
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2017]. Studies using type I diabetic rats have shown decreased tear secretion, altered
wound healing and impaired corneal innervation [Yin et al., 2011].
Dry eye syndrome is reported more frequently in patients of diabetes mellitus.
There is a correlation between the incidence of dry eye and the level of glycated
hemoglobin, with a higher level of glycated hemoglobin, leading to a higher level of
incidence of dry eye [Seifart and Strempel, 1994]. Studies have shown about 45%
prevalence of both symptomatic and asymptomatic dry eye syndrome in patients with
diabetes [Hom and De Land 2006]. Another study reported higher incidence with
approximately 53% of patients with diabetes showing clinical signs of dry eyes [Manaviat
et al., 2008]. These findings were further corroborated by another study also reporting
54% of patients with diabetes having dry eye syndrome, and there was a strong
correlation between the duration of diabetes and dry eye syndrome. In older patients
suffering from diabetes mellitus, the incidence of symptomatic dry eye disease is high,
and it increases further with the advancing age. Furthermore, women suffering from
diabetes mellitus are 50% more likely to get dry eye compared to male patients of
diabetes mellitus [Rosenberg et al., 2000].
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Human Conjunctival Epithelial Cell Culture
Telomerase-immortalized human conjunctival epithelial cells were plated at a
density of 1X106 cells onto a T75 flask (CytoOne® USA Scientific, Inc, Ocala, FL, USA).
The cells were cultured in the supplemented keratinocyte growth medium (Table 1) at
37°C with 5% carbon dioxide and 95% humidity in a cell culture incubator (Forma series
II water jacket, Thermo Fisher Scientific, Marietta, OH, USA). The media was replaced
every two to three days. Once the cells reached 80% confluence, they were trypsinized
and plated [Gipson et al., 2003].
Table 1: Composition of keratinocyte growth medium.
No
1
2
3
4
5

Ingredient
Keratinocyte Serum-Free Medium
Human Epidermal Growth Factor
Bovine Pituitary Extract
Calcium Chloride
Penicillin/Streptomycin

Concentration
0.23ng/ml
25µg/ml
0.4mM
100U/ml

Treatment Protocol
The cells were exposed to either keratinocyte growth medium (control) or
keratinocyte growth medium containing glucose; mannitol (15 mM; 30 mM) for 24h; 72h
(Table 2). All the experiment mentioned below (TEER, Scratch, Gene Expression and
Western blot) were performed in triplicate for each treatment group.
Table 2: Experimental Design
Treatment
High Glucose

Control
Group

24h
5 mM

15 mM

30 mM

High Mannitol

72 h
15 mM

30 mM
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24h
15 mM

30 mM

72h
15 mM

30 mM

Trans-epithelial Electrical Resistance (TEER)
The cells were seeded onto collagen-coated 3.0 μm polytetrafluoroethylene
(PTFE) trans-well membranes inserts (Costar® Corning incorporated, Kennebunk, ME,
USA) placed onto 12-well plates. The cells were allowed to grow to a 100% monolayer.
The trans-epithelial electrical resistance was measured using chopstick electrode method
(Axon® Instruments) [Srinivasan et al., 2015].
Cell Migration Assay
The cells were plated in 12-well plates and allowed to reach 100% confluence. The
scratch was performed on the cells in two perpendicular straight lines using a 1000 μl
pipette tip [Hou., 2013]. The cells were imaged at the same position just above where
the two perpendicular scratch lines intersected at time points immediately after scratch
(0), and then at 6, 12, 24, 48 and 72 hours using a 4X objective phase contrast lens on a
bright-field microscope (Keyence BZ-X 710, Itasca, IL, USA). The re-epithelization of the
scratch area was quantified by measuring the distance between the two edges of the
scratch lines using Image J software [NIH].
Isolation of mRNA and Preparation of cDNA
The cells were plated in a 12-well plate. A commercially available kit (QIAGEN’s
RNeasy Mini Kit) was used to isolate the mRNA from cultured human conjunctival
epithelial cells. Briefly, the media was aspirated from each well and 350 μl of RNase
inhibitor containing RLT buffer was added to each well to cause cell lysis. The lysate was
then transferred to the QIA shredder spin column and centrifuged to further facilitate
shredding.
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The flow-through was collected and an equal volume of 70% molecular biology
grade ethanol was added to the lysate to precipitate the DNA. The lysate was transferred
to the RNeasy spin column which binds RNA. The column was then centrifuged at 10,000
rpm for 30 sec. The column was washed with RW1 buffer and RPE buffer to remove any
residual protein contamination. Lastly, 30 μl of RNase-free water was added to the column
membrane and incubated for five minutes at room temperature followed by centrifugation
for 1 minute to elute the RNA. The isolated RNA was immediately used for cDNA
preparations.
The RNA was reverse transcribed to cDNA using a commercially available kit
(SuperScript® III First-Stand, Invitrogen, CA, USA). A 7 μl sample of isolated RNA was
combined with 1 μl of 50 μM oligo(dT)20 primer, 1 μl of 10mM dNTP mix and 2 μl of DEPCtreated water. The mixture was incubated at 65oC for 5 minutes using MiniAmp
Thermocycler (Applied Biosystems, Thermo Fisher Scientific, Singapore) followed by
incubation on ice for 1 minute. A 10 μl of cDNA Synthesis mix (Table 3) was then added
to the above reaction mixture.
The mixture was incubated at 50oC for 50 minutes and then, at 85oC for 5 minutes.
Lastly, 1 μl RNase H was added to the reaction and incubated at 37oC for 20 minutes.
Table 3: Composition of cDNA synthesis mixture.
No
1
2
3
4
5

Ingredient
10 X RT buffer
25 mM MgCl2
0.1 M DTT
RNaseOUT™ (40 U/ µL)
Superscript® III RT (200 U/ µL)
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Quantity/Reaction
2 µL
4 µL
2 µL
1 µL
1 µL

Real-Time PCR
The gene expression of the tight junction proteins claudin-1,-2,-3, ZO-1,-2,-3 and
occludin was quantified using Real-Time PCR. The PCR master mix was prepared as
shown in the table 4 and using the primers shown in table 5. A total of 20 µl was used per
reaction (1µl cDNA+19 µl of master mix).
Table 4: Composition of Real-Time PCR master mix.
No
Ingredient
1
Bullsey EvaGreen qPCR Master Mix
2
Reverse Primer of Target Gene
3
Forward Primer of Target Gene
4
cDNA Sample
5
DEPC water

Quantity/PCR Reaction
10µl
2µl
2µl
1µl
5µl

QuantStudio™ 3 Real-Time thermocycler (Applied Biosystems, Thermo Fisher Scientific,
Singapore) thermocycler was used to run the PCR reactions.
Table 5: Nucleotide sequences of forward and reverse primers for mRNA of human tight
junction proteins and β-actin.
No

Protein

1

ZO-1

2

ZO-2

3

ZO-3

4

CLA-1

5

CLA-2

6

CLA-3

7

Occludin

8

β-actin

Forward primer
5'-GCA GCC ACA ACC
AAT TCA TAG-3'
5'-AGG ATG CCG TTC
TCT ACC T-3'
5'-GGC GGG AAA GTT
CAG TAG ATT-3'
5'-CCA GTT AGA AGA
GGT AGT GTG AAT-3'
5'-CCT CCA TCC CAC
TCT TGT TAT G-3'
5'-CCA AGG CCA AGA
TCA CCA T-3'
5'-GGA AGG TTC TGG
TGT GAA CTA A-3'
5'-GGA CCT GAC TGA
CTA CCT CAT-3'

Reverse Primer
5'-GAA AGG TAA GGG
ACT GGA GAT G-3'
5'-CAC AAG CCA GGA
TGT CTC TAT AC-3'
5'-GGC ACT CTG TAG
ATG TCA TAG C-3'
5'-CAG CCA GCT GAG
CAA ATA AAG-3'
5'-CAT CCT GCA TCC
TGC TTT CT-3'
5'-GGT TGT AGA AGT
CCC GGA TAA TG-3'
5'-CTG AAA GGT GGT
TGA GAG GAT TA-3'
5'-CGT AGC ACA GCT
TCT CCT TAA T-3'

Accession #
NM_001355015.1
NM_004817.4
NM_001267561.1
NM_021101.4
NM_020384.3
NM_001306.3
NM_002538.4
NM_001101.3

The thermocycler settings for PCR were: Step 1 (Activation): 50oC for 2 minutes
then 95oC for 2 minutes for thermal activation of the modified inactive form of Taq

26

polymerase. Step 2 (PCR): 40 cycles of: 95oC for 15 seconds to cause cDNA
denaturation and 60oC for 1 minute for annealing and extension. Step 3 (Melt Curve):
Continuous: 95oC for 15 seconds then 60oC for 1 minute then 95oC for 15 seconds.
Western Blotting
The protein extracts were prepared by adding radioimmunoprecipitation assay
(RIPA) buffer containing Halt™ protease inhibitor (Thermo Scientific, Rockford, IL, USA)
to the cells. The cells were incubated in RIPA buffer at 4oC for 15 min on a shaker followed
by removal of any adherent cells using a cell scraper. The cells were further lysed by
passing through a 21-gauge needle and incubated on ice for 60 min. The lysate was then
centrifuged at 14,000g for 15 min at 4oC. The supernatant was collected as total cell
lysate. Th protein concentration was determined by BCA method using a commercially
available kit (Pierce™ BCA protein Assay Kit., Thermo Scientific, Rockford, IL, USA). The
protein extracts were suspended in loading buffer containing β-mercaptoethanol (BioRad) and heated at 95oC for 5min. Protein samples were resolved by loading on 10%
SDS-PAGE gels (Mini-PROTEAN® TGX™, Bio-Rad Laboratories Inc, Carlsbad, CA,
USA) and running at 100V for about 85 minutes using 1X TRIS-glycine-SDS buffer. The
resolved proteins were transferred from gel onto the polyvinylidene difluoride membranes
using wet transfer at 100V for 60 minutes. The membranes were blocked in 5% blocking
buffer (5% bovine serum albumin in distilled water) for 1 hour. The membranes were then
incubated with primary antibodies overnight at the concentrations shown in the table 6.
The membranes were washed three times with 0.1% TBST (Tween 20 in Tris buffered
saline), followed by incubation with horse radish peroxidase (HRP)-conjugated secondary
antibody for 1 hour and then three washings with TBST. Glyceraldehyde-3-phosphate
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dehydrogenase (GAPDH), was used as house-keeping gene. The blot was developed
using enhanced chemiluminescence reagent (Lumigen Inc., Southfield, Michigan, USA)
and imaged using a chemiluminescence gel imager (Bio-Rad Laboratories Inc, Carlsbad,
CA, USA). The digital quantification of western blots was performed using Image J
software. The quantification intensity was normalized against GAPDH bands.
Table 6: Polyclonal and monoclonal antibodies used for Western Blot.
No
Primary Antibody
Concentration/per mL
1
ZO-1
2 µg/ml
2
ZO-2
2 µg/ml
3
ZO-3
2 µg/ml
4
CLA-1
2 µg/ml
5
Occludin
1 µg/ml
6
Anti GAPDH
1:10000
No
Secondary Antibody
Concentration/per mL
1
Donkey Anti-Rabbit IgG HRP
1:5000
Mouse Model of Type I Diabetes
The animal protocol was approved by Institutional Animal Care and Use
Committee of Chapman University. Female C57BL/6 mice (Charles River Laboratories,
Wilmington, MA, USA) 6 weeks old and weighing from 16-18 were used in this study. To
induce type I diabetes, the mice were injected with a single intraperitoneal dose of 200
mg/kg streptozotocin dissolved in citrate buffer, pH 4.5 [Deeds et al., 2011].
Blood Glucose Monitoring
The blood glucose was monitored by nicking the tail to collect a blood drop in a
glucose strip. The blood glucose was quantified using a glucometer (OneTouch Verio IQ®
Life Scan Europe, China).
Tear Quantification
The tear secretion was quantified in both eyes using the commercially available
phenol red thread (Zone Quik, FCI Ophthalmic, Japan). Briefly, the thread was placed in
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the lower eyelid of the mice for 60 seconds. The phenol red thread is pH sensitive and
when wetted by tears changes from yellow to red. After 1 minutes, the thread was
removed and the length of the red color was measured in millimeters [Choi et al., 2015;
Choi, 2016].
Fluorescein Staining and Keratopathy Scoring
The mice were anesthetized using ketamine (80 mg/kg) and xylazine (5 mg/kg). A
2 µl sterile solution of 0.1% of sodium fluorescein was applied to both eyes followed by
washing with 1X PBS. After 10 minutes, the mice were imaged under cobalt blue filter
using a slit-lamp (Kowa SL-17, Japan) equipped with a digital camera. The captured
corneal images were divided into four hypothetical quadrants for scoring the keratopathy
using a previously published method [Zhang et al., 2014]. Each quadrant was scored as
follows: no staining = 0; slightly punctate staining less than 30 spots = 1; punctate staining
more than 30 spots, but not diffuse = 2; diffuse staining but no positive plaque = 3; positive
fluorescein plaque = 4. The scores of each quadrant were added to arrive at a final grade
(total maximum possible score = 16). Corneal keratopathy scoring was not performed in
blinded manner.
Tissue Harvesting and Cornea Isolation
The mice were euthanized with CO2 using AVMA compliant equipment. The right
eyelids along with the eyeballs was harvested and fixed in 4% paraformaldehyde
overnight followed by gradient dehydration by immersing in with 15% sucrose for 24 hours
and 30% of sucrose for another 24 hours. The corneas were isolated under a dissecting
microscope.
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Glycocalyx staining, Confocal imaging and Quantification
The corneas were placed in a 12-well plate and washed with 1X PBS on a shaker
for 5 minutes followed by blocking with 5% bovine serum albumin for 20 minutes. The
corneas were then stained with Alexa 488 conjugated wheat germ agglutinin (Thermo
Fisher Scientific, Hanover Park, IL, USA) using a dilution of 1.5 µl of stock solution in 1
mL of 1X PBS for 20 minutes at room temperature [Kataoka et al., 2016]. The corneas
were then washed with 1X PBS for 10 minutes twice. The stained corneas were then
placed on a slide followed by DAPI containing mounting media. The corneas were imaged
using confocal microscope. The quantification of glycocalyx stained area was performed
using Image J software (provided in the public domain by the National Institutes of Health,
Bethesda, MD, USA) but was not performed in a blinded manner.
Statistical Analysis
All the experiments were performed in triplicate for each treatment group. The data
is presented as mean + Standard error of mean. Statistical analysis was performed using
GraphPad Prism software (Version 8, San Diego, CA, USA). The cell culture data was
analyzed using Two-Way ANOVA followed by Tukey’s post-hoc test for multiple
comparisons. The statistical analysis for animal studies was done using One-Way
ANOVA followed by Dunnett’s post-hoc test. A p value of <0.05 was considered
statistically significant.
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Effect of High Glucose on Trans-Epithelial Electrical Resistance (TEER)
To test whether high glucose causes an impairment of conjunctival epithelial cell
barrier functions, we cultured a monolayer of human conjunctival epithelial cells on a
trans-well membrane. Typically, monolayer of conjunctival epithelial cells with intact
barrier functions shows high electrical resistance across the apical to basal surface
making TEER a reliable test [Srinivasan et al., 2015]. Chopstick electrodes placed on the
top and bottom of the monolayer were used to measure TEER. As is shown in Figure 9A,
treatment of human conjunctival epithelial cells with 15 and 30mM glucose caused an
average of 14% and 5% decrease in TEER after 72 hours of exposure (* p< 0.05
compared to control cells exposed to media containing normal concentration of glucose).
No significant decrease in TEER was observed at 24 hours suggesting that a persistent
exposure to high glucose may be required to cause an impairment of barrier functions.
It should be noted that mannitol only at 30 mM concentration caused a 4%
decrease in TEER after 72 hours of exposure whereas 15 mM of mannitol did not cause
any notable decrease in TEER either after 24 or 72 hours of exposure (Figure 9B).
Effect of High Glucose on Cell Migration
To test the effect of high glucose exposure on cellular migration of conjunctival
epithelial cells, we used the scratch assay. Figure 10 shows the representative phase
contrast microscopy images of conjunctival epithelial cells exposed to high glucose and
mannitol respectively at various tested time points after preforming the scratch wounding.
The quantification of the scratch length as a percentage change to the baseline
length showed that high glucose (Figure 11A) and mannitol (Figure 11B) had no effect on
the time dependent decrease in the scratch length. The data suggests that neither high
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glucose nor mannitol had any significant effect on the migration of human conjunctival
epithelial cells.
Effect of High Glucose on Claudin Family Gene and Protein Expression
Tight junctions play an important role in maintaining the cellular barrier functions
[Itoh and Bissell, 2003; Anderson and Van Itallie, 2009; Lee et al., 2018]. Claudin family
of proteins are integral part of tight junctions [Itoh and Bissell, 2003; Anderson and Van
Itallie, 2009; Lee et al., 2018]. Therefore, we next tested the effect of high glucose
exposure on the gene and protein expression of claudin-1,2 and 3. Figure 12A shows that
glucose at 15 mM concentration caused an average of 4.81-fold increase in claudin-1
gene expression after 72 hours exposure (* p< 0.05 compared to control cells exposed to
media containing normal concentration of glucose). On the other hand, glucose at 30 mM
concentration did not modulate claudin-1 gene expression either with 24- or 72-hours
exposure. Figure 12B shows that mannitol also caused a significant 3.4- and 2.2-fold
increase in claudin-1 at 15mM and 30mM after 72 hours of exposure (* p< 0.05 compared
to control cells exposed to media containing no mannitol).
Figure 13A shows that glucose 15mM concentration caused a 2.31-fold increase
in claudin-3 gene expression after 72 hours exposure (* p< 0.05 compared to control cells
exposed to media containing normal concentration of glucose). As can be seen in Figure
13B, mannitol also caused a significant 2.74- and 1.74- fold increase in claudin-3 at both
15mM and 30mM after 72 hours of exposure (* p< 0.05 compared to control cells exposed
to media containing no mannitol). In contrast to claudin-1 and claudin-3, high glucose and
high mannitol did not cause any significant change in claudin-2 gene expression (Figure
13).
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We further tested the effect of high glucose exposure on protein expression of
claudin family of proteins. High glucose or high mannitol did not cause any significant
change in claudin-1 protein expression either at 24 or 72 hours of exposure (Figure 14).
Furthermore, claudin 2 or claudin 3 protein expression could not detected in conjunctival
epithelial cell extracts using western blot.
Effect of High Glucose on Zonula Occludens Family Gene and Protein Expression
Zonula occludens (ZO) family of proteins tether the cytoplasmic chain of claudin
proteins to the cytoskeletal actin filaments [Itoh and Bissell, 2003; Ban et al., 2003;
Anderson and Van Itallie, 2009; Lee et al., 2018]. Therefore, we next tested the effect of
high glucose exposure on zonula occludens family of proteins. Figure 15A shows that 15
mM glucose caused an average of 1.81-fold increase in ZO-1 gene expression after 72
hours exposure (* p< 0.05 compared to control cells exposed to media containing normal
concentration of glucose). Figure 15B shows that mannitol also caused a significant 1.52fold increase in ZO-1 at 15mM after 72 hours of exposure (* p< 0.05 compared to control
cells exposed to media containing no mannitol). It should be noted that no change in ZO1 gene expression was observed with glucose or mannitol exposure after 24 hours.
In contrast to the noted increase in ZO-1 gene expression, high glucose or high
mannitol did not cause any significant change in ZO-1 protein expression either at 24 or
72 hours of exposure (Figure 16).
Figure 17A shows that 15 mM glucose caused a 3.71-fold increase in ZO-2 gene
expression after 72 hours exposure (* p< 0.05 compared to control cells exposed to media
containing normal concentration of glucose). Figure 17B shows that mannitol also caused
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a 2.69- and 1.85-fold increase in ZO-2 at 15mM and 30mM after 72 hours of exposure
(*p< 0.05 compared to control cells exposed to media containing no mannitol).
However, high glucose or high mannitol exposure did not cause any significant
change in ZO-2 protein expression either at 24 or 72 hours of exposure (Figure 18).
Finally, we also tested the effect of high glucose exposure on the gene and protein
expression of ZO-3. Figure 19 shows that 15 mM glucose caused a significant 4.75-fold
increase in ZO-3 gene expression after 72 hours exposure (* p< 0.05 compared to control
cells exposed to media containing normal concentration of glucose). Similar to glucose,
mannitol also caused a significant 3- and 1.71-fold increase in ZO-3 at 15mM and 30mM
after 72 hours of exposure (*p< 0.05 compared to control cells exposed to media
containing no mannitol).
As was the case with claudin-1, ZO-1 and ZO-2, high glucose or high mannitol did
not cause any significant change in ZO-3 protein expression either at 24 or 72 hours of
exposure (Figure 20).
Effect of High Glucose on Occludin Gene and Protein Expression
Figure 21 shows that 15 mM glucose caused a significant 2.66-fold increase in
occludin gene expression after 72 hours exposure (* p< 0.05 compared to control cells
exposed to media containing normal concentration of glucose). Similar to glucose,
mannitol also caused a significant 1.89-fold increase in Occludin at 15mM after 72 hours
of exposure (*p< 0.05 compared to control cells exposed to media containing no
mannitol).
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Just like claudin-1 and ZOs, high glucose or high mannitol did not cause any
significant change in occludin protein expression either at 24 or 72 hours of exposure
(Figure 22).
Induction of Type I diabetes
Figure 23 shows the random postprandial blood glucose levels in mice injected
with a single intraperitoneal dose of streptozotocin (200 mg/kg). A mean blood glucose
levels of 500 and 530 mg/dl were noted at week 1 and week 2 respectively after
streptozotocin injection which were significantly (p<0.05) high compared to the average
baseline blood glucose levels in these mice. The high blood glucose values after
streptozotocin administration confirmed the onset of type I diabetes in these mice.
Effect of Type I diabetes mellitus on Tear Secretion
Figure 23 shows a mean baseline phenol red thread value of 3.3 mm in mice. At 1
week after the onset of hyperglycemia due to diabetes mellitus, a significant (p<0.05) drop
in the phenol red thread test values was noted suggesting a decrease in the tear film. A
partial recovery in this noted decrease in tear film was observed at week 2 after the
induction of diabetes suggesting the possibility of a compensatory response by lacrimal
functional unit.
Effect of Type I diabetes mellitus on Corneal Keratopathy
The top panel in figure 24 shows representative fluorescein images of mouse
corneas before and at week 1 and week 2 after the onset of diabetes-associated
hyperglycemia. As can be seen in the images, corneas of diabetic mice show corneal
punctate and plaque staining. Quantification of fluorescein stained images showed a
mean score of 5 and 9 at week 1 and week 2 respectively after the onset of diabetes
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mellitus suggesting the presence of corneal keratopathy in these mice. The decrease in
tear film typically precedes the onset of keratopathy which explain the higher score of
corneal keratopathy observed at week 2 as compared to week 1.
Effect of Type I diabetes mellitus on Corneal Glycocalyx
Corneal epithelial cells express membrane-tethered mucins MUC1, MUC4 and
MUC 16 on their apical surface [Mantelli et al., 2013]. Galectin 3 forms a continuous
network with these membrane-tethered mucins to form glycocalyx [Mantelli et al., 2013].
Wheat germ agglutinin lectin binds to the sialic acid residues present on these mucins
and has been previously used to stain the corneal glycocalyx [Kataoka et al., 2016;
Shamloo et al., 2019]. The top panel in figure 25 shows the Z-stack confocal images of
the mouse corneas stained for glycocalyx using Alexa 488-conjugated wheat germ
agglutinin. The top view of confocal z stack images shows a dense and uniformly
distributed glycocalyx staining in the corneas of control mice. On the other hand, corneal
glycocalyx is sparse and patchy in the corneas obtained from mice at week 1 and week
2 after the onset of diabetes mellitus. The glycocalyx-stained area was quantified as a
percentage of the total area using binary image analysis. As can be seen from the
quantification data presented in figure 25, a significant (p<0.05) decrease of 20% and
12% in glycocalyx-stained area was observed in the cornea of mice at week 1 and week
2 after the onset of diabetes mellitus.
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Figure 9: Effect of high glucose (A) and mannitol (B) on transepithelial electrical resistance (TEER) in cultured human conjunctival
epithelial cells.
* p<0.05 compared to control
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Figure 10: Representative phase contrast microscopy images showing the
effect of glucose (Left) and mannitol (Right) on migration of human
conjunctival epithelial cells measured using scratch assay.
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Figure 11: Time-dependent effect of high glucose (A) and mannitol (B) on
migration of human conjunctival epithelial cells measured over 72 hours as a
percent change in the length of scratch compared to the length at the start
(Baseline).
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Figure12: Effect of high glucose (A) and mannitol (B) on claudin-1
gene expression in human conjunctival epithelial cells quantified
using real-time PCR.
* p<0.05 compared to control
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Figure13: Effect of high glucose (A) and mannitol (B) on claudin-2 (Left) and claudin3 (Right) gene expression in human conjunctival epithelial cells quantified using
real-time PCR.
* p<0.05 compared to control
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Figure 14: Effect of high glucose (A) and mannitol (B) on claudin-1 protein
expression in human conjunctival epithelial cells quantified using western
blotting and densitometric image analysis.
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Figure 15: Effect of high glucose (A) and mannitol (B) on ZO-1 gene
expression in human conjunctival epithelial cells quantified using
real-time PCR.
* p<0.05 compared to control
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Figure 16: Effect of high glucose (A) and mannitol (B) on ZO-1 protein expression
in cultured human conjunctival epithelial cells quantified using western blotting
and densitometric image analysis.
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Figure 17: Effect of high glucose (A) and mannitol (B) on ZO-2 gene
expression in human conjunctival epithelial cells quantified using
real-time PCR.
* p<0.05 compared to control
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Figure 18: Effect of high glucose (A) and mannitol (B) on ZO-2 protein expression
in cultured human conjunctival epithelial cells quantified using western blotting
and densitometric image analysis.
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Figure 19: Effect of high glucose (A) and mannitol (B) on ZO-3 gene
expression in human conjunctival epithelial cells quantified using
real-time PCR.
* p<0.05 compared to control
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Figure 20: Effect of high glucose (A) and mannitol (B) on ZO-3 protein expression
in cultured human conjunctival epithelial cells quantified using western blotting
and densitometric image analysis.
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Figure 21: Effect of high glucose (A) and mannitol (B) on occludin
gene expression in human conjunctival epithelial cells quantified
using real-time PCR.
* p<0.05 compared to control
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Figure 22: Effect of high glucose (A) and mannitol (B) on occludin protein
expression in cultured human conjunctival epithelial cells quantified using
western blotting and densitometric image analysis.
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Figure 23: Random post-prandial blood glucose levels (Top Panel) and Tear
volume (Bottom Panel) in mice prior to (Before Diabetes) and at week 1 and week
2 (After Diabetes) after a single intraperitoneal injection of streptozotocin
* p< 0.05 compared to before diabetes

52

Figure 24: Corneal keratopathy score in mice prior to (Before Diabetes) and at
week 1 and week 2 (After Diabetes) after a single intraperitoneal injection of
streptozotocin measured using images obtained from slit-lamp after
fluorescein staining.
* p< 0.05 compared to before diabetes
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Figure 25: Quantification of glycocalyx in corneas obtained from nondiabetic
mice and mice at week 1 and week 2 (Diabetic) after a single intraperitoneal
injection of streptozotocin measured using alexa-488 conjugated wheat germ
agglutinin staining and confocal microscopy.
* p< 0.05 compared to Non-diabetic
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CHAPTER V
DISCUSSION
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Diabetes mellitus has been shown to cause loss of barrier function in many organs.
Induction of diabetes mellitus in animals or exposure of cultured cells to high glucose has
been shown to cause an impairment in the transport and integrity of blood brain barrier
microvessels, changes in intestinal permeability and a compromise of selective
glomerular barrier filtration [Hawkins et al., 2007; Prasad et al., 2014; Mongelli-Sabino et
al. 2017; Thaiss et al., 2018; Shen et al., 2019;; Eftekhari et al., 2020]. In the ocular tissue,
high glucose exposure of cultured retinal epithelial cells has been shown to compromise
the barrier functions [Villarroel et al., 2009; Xia et al., 2017]. The present study for the first
time demonstrated that high glucose exposure can also compromise the barrier function
of cultured human conjunctival epithelial cells as indicated by a decrease in TEER. It is
worthwhile to note that a significant decrease in TEER was observed only at 72 hours
suggesting that a persistent exposure to high glucose is likely to cause a decrease in
conjunctival epithelial cell barrier function whereas conjunctival cells may be able to
tolerate transient high glucose exposure with any notable detrimental effect. Our lab has
also observed a similar trend in high glucose-mediated decrease in TEER in corneal
epithelial cells as well.
Under normal physiological conditions, conjunctival epithelial cells in the eye
undergo a quick turnover of about 72 hours [Van Buskirk, 1989; Chigbu, 2013; Sridhar,
2018]. Newly formed conjunctival epithelial cells generated at the limbus migrate to the
sclera and eyelids to form a normal protective barrier [Van Buskirk, 1989; Chigbu, 2013;
Sridhar, 2018]. Thus, an impairment of conjunctival epithelial cellular migration can
significantly compromise the barrier functions. However, our data demonstrates that high
glucose exposure does not affect the migration of human conjunctival epithelial cells, thus
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suggesting that impairment of cellular migration of human conjunctival epithelial cells may
not contribute to the high glucose-associated impairment of barrier functions.
Intercellular adhesion junctions are critical for maintaining the normal barrier
functions of epithelial and endothelial cells [Itoh and Bissell, 2003; Anderson and Van
Itallie, 2009; Lee et al., 2018]. Three such class of cell to cell adhesion junctions include
tight junctions, adherens junctions, and desmosome. Among these junctions, tight
junctions provide the most critical barrier function regulating the intercellular passage of
molecules and ions based on their size and composition [Itoh and Bissell, 2003; Anderson
and Van Itallie, 2009; Lee et al., 2018; Bhat et al., 2019]. Tight junctions also serve the
‘fence function’ by restricting the movement of molecules in the plasma membrane from
apical to basolateral side. Adherens junctions, on the other hand, join the actin filaments
of adjacent cells together thus providing the structural adherence function [Niessen, 2007;
Campbell et al., 2017; Shigetomi et al., 2018]. Desmosomes provide even stronger
adherence by linking the intermediate filaments between the adjacent cells [Garcia et al.,
2018]. Since tight junctions provide the most critical function of providing the barrier,
therefore we next tested the effect of high glucose exposure on the protein and gene
expression of various components of tight junctions to delineate their role in the noted
decrease in barrier function of conjunctival epithelial cells after high glucose exposure.
Claudins are the backbone of tight junctions and play an essential in their barrier
function [Krause et al., 2008; Tsukita et al., 2019]. Claudins can be classified as closed
or selectively permeable [Bhat et al., 2019]. Claudin-1 and claudin-3 belong to the closed
group while claudin 2 is selectively permeable to anions and water [Bhat et al., 2019].
Conjunctival epithelial cells have been shown to express high levels of claudin-1 [Yoshida
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et al., 2009]. In agreement with the previously published report [Yoshida et al., 2009], our
data also demonstrated high mRNA and protein expression of claudin-1 in the
conjunctival epithelial cells. However, exposure of human conjunctival epithelial cells to
high glucose did not modulate the protein expression of claudin 1. Interestingly, high
glucose at 15 mM caused an increase in the gene expression of claudin-1 after 72 hours
of exposure. Our data also demonstrated the detection of claudin-2 and claudin-3 mRNA
transcripts but we were unable to detect the protein levels claudin 2 and claudin 3
suggesting that these two claudins may not be physiologically relevant for contributing to
the barrier function of human conjunctival epithelial cells.
Claudins have a conserved PDZ domain through which they interact with the
intracellular ZO molecules to provide an anchoring function [Krause et al., 2008; Campbell
et al., 2017; Tsukita et al., 2019]. Since high glucose did not affect the protein expression
of claudin-1, we next tested the possibility that high glucose may compromise the
anchoring of claudin-1 by decreasing the levels of ZO proteins. Our data demonstrates
the presence of mRNA transcripts and protein levels of all the three members of ZO family
(i.e ZO1, 2 and 3) in the human conjunctival epithelial cells. Our data is in agreement with
previous reports showing the presence of ZOs in human conjunctival epithelial cells
[Yoshida et al., 2009]. However, exposure of human conjunctival epithelial cells to high
glucose did not modulate the proteins levels of any of the three ZOs. On the other hand,
high glucose at 15 mM, exactly like its effect on claudin-1, caused an increase in the gene
expression of ZO1, 2, and 3 after 72 hours exposure.
Lastly, we tested the effect of high glucose exposure on occludin. Occludin is the
protein present in the tight junctions that acts as a zipper to hold the adjacent cells [Krause
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et al., 2008; Cummins, 2012]. Our data shows the presence of mRNA transcript and
protein levels of occludin in human conjunctival epithelial cells. However, exposure of
human conjunctival epithelial cells to high glucose had no impact on its protein levels. In
a surprisingly consistent manner along with the claudin-1, ZO 1, 2 and 3, high glucose at
15 mM caused an increase in the occludin gene expression as well after 72-hour
exposure.
Overall, our data suggests that a decrease in the protein expression of claudin-1,
ZOs family and occludin is not the likely underlying cause to the observed high glucose
exposure-mediated impairment of human conjunctival epithelial cells barrier function.
Besides claudin-1, human conjunctival epithelial cells have also been reported to express
other claudins such as claudin-4 and claudin-10 [Yoshida et al., 2009]. Therefore, it is
possible that high glucose-mediated decrease in claudins-4 or 10 may contribute to the
noted decrease in barrier function and may be addressed by the future studies. It is also
possible that tight junction protein components, other than claudins, ZOs and occludin,
may be impacted by high glucose and may be contributing to the compromised barrier
function. Lastly, our study did not test the impact of high glucose of the phosphorylation
status or confirmation changes of intercellular junction proteins. Such alteration can also
contribute to high glucose-mediated compromise of barrier function with causing any
decrease in the protein levels. An observed increase in the gene expression of the tight
junction proteins as observed in the present study may be a compensatory cellular
response to preserve the barrier functions and to partial circumvent the damaging effect
of high glucose exposure. This hypothesis is especially supported by the fact the
observed increase was only observed at 15 mM glucose and was a delayed response.
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This effect on gene expression is likely due to the cellular osmotic stress caused by
glucose since mannitol at the same concentration also caused the similar increase after
72 hours exposure. On the other hand, detrimental effect of 30 mM glucose or mannitol
may be too high to overwhelm any compensatory cellular response.
Membrane-tethered mucins along with galectin form ocular surface glycocalyx
which together with tight junction provide additional barrier functions and keeps the eye
surface hydrated and lubricated [Mantelli et al., 2013]. Previous studies in our lab have
demonstrated that high glucose can adversely affect the expression of membranetethered mucins in human corneal and conjunctival epithelial cells [Unpublished data].
Therefore, we further tested the effect of diabetes mellitus on glycocalyx using a mouse
model of type I diabetes mellitus. In agreement with our in vitro data, we notice that type
I diabetes mellitus caused a significant decrease in the area of corneal glycocalyx. This
decrease in glycocalyx was accompanied by a concomitant reduction in the volume of
tear film suggesting the onset of dry eye. It is interesting to notice that a partial recovery
in glycocalyx area and tear film volume was observed at week 2 after the onset of diabetes
as compared to week one. This partial recovery suggests that increased tear secretion
from other lacrimal functional units such as meibomian gland or lacrimal gland may try to
compensate for the diabetes-mediated damage to the glycocalyx. It is likely that the
persistent hyperglycemia may continue to cause further damage to the glycocalyx and
can also be detrimental to other parts of lacrimal functional units, thus eventually causing
more severe dry eye. To answer these questions, we need to perform longer duration
studies for 4- 8 weeks after the induction of diabetes and such studies are currently
underway in our lab.
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CHAPTER VI
CONCLUSION
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The results of our data demonstrate that exposure of conjunctival epithelial cells
to high glucose causes a decrease in trans-epithelial electrical resistance, suggesting that
high glucose causes impairment of conjunctival epithelial barrier function. However,
exposure of conjunctival epithelial cells to high glucose did not impact cellular migration
at various time points. Further, our data also demonstrated that exposure of conjunctival
epithelial cells to high glucose did not cause any change in protein expression of claudin1, ZO-1, ZO-2, ZO-3, and occludin suggesting that a decrease in tight junction proteins
may not account for the impairment of barrier function. On the other hand, exposure of
conjunctival epithelial cells to high glucose caused an increase in gene expression of
claudin-1, ZO-1, ZO-2, ZO-3, and occludin at 72 hours suggesting a likely compensatory
physiological response to counter the detrimental effects of high glucose on barrier
functions. Animal studies using type I mouse model of diabetes mellites showed a
significant decrease in the tear film and presence of corneal epithelial defects, suggesting
that diabetes mellites cause tear film dysfunction which may underlie diabetes mellitesassociated corneal keratopathy. The tear film dysfunction and corneal keratopathy were
accompanied by a concomitant decrease in the area of corneal glycocalyx.
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APPENDIX
MATERIALS

ITEM SUPPLIER

Human conjunctival epithelial cells

Dr. Ilene Gipson Harvard Medical School

Keratinocyte serum free medium

Gibco

PTFE Trans-well membranes.

Costar® Corning incorporated

Bright-field microscope

Keyence BZ-X 710

RNeasy Mini Kit

QIAGEN

QuantiNova Reverse Transcription Kit

QIAGEN

SuperScript® III First-Stand

Invitrogen

Reverse and Forward primer of claudin-1, claudin-2, claudin-3, ZO-1, ZO -2, ZO -3,
occludin, and ß- actin

Integrated DNA Technologies

RIPA buffer

Thermo Scientific

BCA protein Assay Kit

Thermo Scientific

Loading buffer

Bio-Rad

Mini-PROTEAN Gel

Bio-Rad

1X TRIS-glycine-SDS buffer

Bio-Rad

TBST

Bio-Rad

Chemiluminescence reagent

Lumigen Inc

Polyclonal and monoclonal antibodies

Thermo Scientific

C57BL/6 mice

Charles River Laboratories

Blood glucose glucometer

Life Scan Europe

Phenol red thread

FCI Ophthalmic

Alexa 488 conjugated wheat germ agglutinin
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Thermo Fisher Scientific
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